Open AccessP1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC‐U02, A NON‐VIRAL GENOME TARGETING, ANTI‐CD19 UNIVERSAL CAR‐T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA PATIENTS
Author(s) -
Hao M.,
Yin D.,
Li Y.,
Gi Y.,
Tian J.,
Guo H.,
Fan D.,
Qin W.,
Liu Q.,
Wang W.,
Li L.,
Peng Z.,
Liu L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848664.50083.13
Subject(s) - cd52 , cytokine release syndrome , alemtuzumab , medicine , human leukocyte antigen , lymphoma , immunology , refractory (planetary science) , t cell , cd19 , antibody , oncology , chimeric antigen receptor , biology , immune system , antigen , astrobiology